Investigating the Neuronal Signals Initiating Synapse Loss in Aging and Alzheimer's Disease

研究衰老和阿尔茨海默病中引发突触丢失的神经信号

基本信息

  • 批准号:
    10313596
  • 负责人:
  • 金额:
    $ 3.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

Abstract: Late-onset Alzheimer’s disease (LOAD) targets the association cortices to cause profound dementia, and available treatments do not alter disease progression. The greatest risk factor for LOAD is advanced age, yet it is unknown why the aging association cortices are vulnerable to degeneration. Cognitive impairment tightly correlates with synapse loss in the dorsolateral prefrontal association cortex (dlPFC), which subserves higher-order cognition. Mouse models have shown that microglia can remove synapses by interacting with molecular “tags” on neurons, including complement (C1q) and phosphatidylserine (PS). However, it is unclear what upstream changes within neurons trigger the generation of these molecules, and whether these mechanisms are activated in the aging dlPFC. The proposed research will utilize an aged rhesus macaque model with mechanistic in vitro experiments, to identify the intraneuronal mechanisms that contribute to synapse loss in the aging association cortex. Aging rhesus macaques have an expanded dlPFC and naturally develop cognitive deficits, plaques and tangles, complement C1q expression, and region-specific synapse loss. Aged macaques also develop an abnormal mitochondrial phenotype termed “Mitochondria-on-a- string” (MOAS) that is seen in human LOAD. I hypothesize that MOAS may arise from chronic calcium (Ca2+) overload of mitochondria, generating molecules participating in synapse removal, including activated C1q, PS, and Caspase 3. Synapses in dlPFC are especially vulnerable to Ca2+ dysregulation as they express cAMP- protein kinase A (PKA) signaling to magnify internal Ca2+ release through ryanodine receptor 2 (RyR2) and inositol triphosphate receptor type 1 (IP3R1). This process is regulated by the phosphodiesterase PDE4D in young brain, which is lost with advancing age. I hypothesize that sustained elevations in cytosolic calcium leads to Ca2+ overload of mitochondria and the induction of MOAS with advancing age, leading to the expression of molecules (C1q, PS, and cleaved caspase 3) that mediate synapse removal by nearby microglia. Aims 1 and 2 will utilize high resolution immuno-Electron Microscopy (EM) and 3D EM reconstruction to elucidate the interactions between MOAS, and (Aim 1) molecules known to mediate synapse removal, and (Aim 2) markers of Ca2+ dysregulation in the dlPFC of young vs. aged macaques. Preliminary data indicate that MOAS preferentially associate with C1q and are more frequent under conditions when PDE4D expression is absent. Aim 3 will use primary murine cortical neuron cultures, immunofluorescence, super-resolution microscopy, and biochemistry to model Ca2+ dysregulation in vitro and test whether chronically elevated Ca2+ levels can induce the MOAS phenotype and generate the molecules mediating synapse removal. Relevant in vitro findings will be cross-validated in the macaque tissue. Identification of the intraneuronal events that lead to synapse loss in the vulnerable aging cortex will provide key insights into how advancing age contributes to LOAD pathogenesis, and help identify potential targets for early therapeutic interventions.
翻译后摘要:迟发性阿尔茨海默病(LOAD)的目标是协会皮层,造成深刻的 痴呆症,可用的治疗不会改变疾病的进展。LOAD的最大风险因素是 尽管老年人的大脑皮层已经进入老年,但尚不清楚为什么衰老的联合皮层容易退化。认知 损伤与背外侧前额叶联合皮层(dlPFC)的突触丢失密切相关, 有助于高阶认知。小鼠模型显示,小胶质细胞可以通过以下方式移除突触: 与神经元上的分子“标签”相互作用,包括补体(C1 q)和磷脂酰丝氨酸(PS)。 然而,目前还不清楚神经元内的上游变化触发了这些分子的产生, 这些机制是否在老化的dlPFC中被激活。这项研究将利用一个古老的 恒河猴模型与机械体外实验,以确定神经元内机制, 会导致老化的联合皮层中的突触丢失。衰老的恒河猴有一个扩大的dlPFC 并自然发展认知缺陷,斑块和缠结,补体C1 q表达,以及区域特异性 突触丧失老年猕猴也会出现一种异常的线粒体表型,称为“线粒体上的”。 在人类的LOAD中看到的字符串”(MOAS)。我推测MOAS可能是由慢性钙(Ca 2+)引起的。 线粒体超载,产生参与突触清除的分子,包括激活的C1 q,PS, Caspase 3 dlPFC中的突触特别容易受到Ca 2+失调的影响,因为它们表达cAMP- 蛋白激酶A(PKA)信号传导通过兰尼碱受体2(RyR 2)放大内部Ca 2+释放, 肌醇三磷酸受体1型(IP 3R 1)。这一过程由磷酸二酯酶PDE 4D调节, 年轻的大脑,随着年龄的增长而丢失。我推测细胞内钙离子的持续升高 导致线粒体Ca 2+超载和MOAS的诱导,导致 通过附近的小胶质细胞介导突触移除的分子(C1 q、PS和裂解的半胱天冬酶3)的表达。 目标1和2将利用高分辨率免疫电子显微镜(EM)和3D EM重建, 阐明MOAS和(目标1)已知介导突触清除的分子之间的相互作用, (Aim 2)年轻与老年猕猴dlPFC中Ca 2+失调的标志物。初步数据表明 MOAS优先与C1 q相关,并且在PDE 4D表达被抑制的条件下更常见。 无托叶目的3将使用原代小鼠皮层神经元培养,免疫荧光,超分辨率 显微镜和生物化学来模拟体外Ca 2+失调,并测试慢性升高的Ca 2+是否 水平可以诱导MOAS表型并产生介导突触去除的分子。适用于 将在猕猴组织中交叉验证体外发现。识别导致神经元内事件 在脆弱的老化皮层突触损失将提供关键的见解如何推进年龄有助于 LOAD发病机制,并帮助确定早期治疗干预的潜在目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Elizabeth Ka-yoon Woo其他文献

Elizabeth Ka-yoon Woo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Elizabeth Ka-yoon Woo', 18)}}的其他基金

Investigating the Neuronal Signals Initiating Synapse Loss in Aging and Alzheimer's Disease
研究衰老和阿尔茨海默病中引发突触丢失的神经信号
  • 批准号:
    10671547
  • 财政年份:
    2021
  • 资助金额:
    $ 3.09万
  • 项目类别:
Investigating the Neuronal Signals Initiating Synapse Loss in Aging and Alzheimer's Disease
研究衰老和阿尔茨海默病中引发突触丢失的神经信号
  • 批准号:
    10477969
  • 财政年份:
    2021
  • 资助金额:
    $ 3.09万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.09万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 3.09万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.09万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.09万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.09万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.09万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.09万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 3.09万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 3.09万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 3.09万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了